Tvardi Therapeutics Stock Forecast

TVRD's stock price has decreased by -94.31% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

According to 9 analysts polled by S&P Global, Tvardi Therapeutics stock has a consensus rating of "Buy" and an average price target of $9.50. The average 1-year stock price forecast is 408.02% higher than the current stock price, while the lowest is $3.00 (+60.43%) and the highest is $14 (+648.66%).

Price Target: $9.50 (+408.02%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$3.00	$9.50	$10	$14
Change	+60.43%	+408.02%	+434.76%	+648.66%

Analyst Ratings

The average analyst rating for Tvardi Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	4	4	4	5	5	4
Buy	0	0	0	0	2	2
Hold	4	3	3	3	1	1
Sell	0	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	8	8	8	9	9	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Elemer Piros Lucid Capital	Lucid Capital	Buy Initiates $6 → $14	Buy	Initiates	$6 → $14	+648.66%	Sep 8, 2026
Sara Nik H.C. Wainwright	H.C. Wainwright	Buy Maintains $9	Buy	Maintains	$9	+381.28%	Aug 21, 2026
Unknown Analyst Cantor Fitzgerald No rating	Cantor Fitzgerald	Hold Maintains n/a	Hold	Maintains	n/a	n/a	Aug 20, 2026
Julian Harrison BTIG	BTIG	Buy Maintains $5	Buy	Maintains	$5	+167.38%	Aug 20, 2026
Etzer Darout Barclays	Barclays	Sell Maintains $3	Sell	Maintains	$3	+60.43%	Aug 20, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-2.32

from -2.46

EPS Next Year

-2.24

from -2.32

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-
Operating Income	-21.19M	-18.67M	-28.11M	-26.75M	-25.91M
Net Income	-20.54M	-17.35M	-29.40M	-18.21M	-25.62M
EPS	-	-	-	-2.46	-2.32
Free Cash Flow	-	-15.13M	-6.91M	-15.22M	-26.88M
No. Analysts	-	-	-	-	8

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2026	2027	2028
High	-1.60
Avg	-2.32
Low	-3.02

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-